Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Nucor Corp ha un obiettivo di prezzo di consenso pari a $158.81, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Jefferies y JP Morgan il agosto 14, 2025, julio 31, 2025 y julio 14, 2025. Con un obiettivo di prezzo medio di $159 tra le Wells Fargo, Jefferies y JP Morgan, c'è un implicito 6.96% upside per Nucor Corp da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Jefferies
JP Morgan
Morgan Stanley
BMO Capital
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Nucor
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/14/2025 | -2.46% | Wells Fargo | — | → $145 | Initiates | → Equal-Weight | ||
07/31/2025 | 14.36% | Jefferies | $135 → $170 | Upgrade | Hold → Buy | |||
07/14/2025 | 8.98% | JP Morgan | $143 → $162 | Maintains | Overweight | |||
06/20/2025 | 0.24% | Morgan Stanley | $134 → $149 | Maintains | Overweight | |||
06/02/2025 | -2.46% | BMO Capital | $140 → $145 | Upgrade | Market Perform → Outperform | |||
05/29/2025 | -1.11% | UBS | $153 → $147 | Maintains | Buy | |||
04/16/2025 | -5.82% | JP Morgan | $156 → $140 | Maintains | Overweight | |||
04/07/2025 | 13.69% | Goldman Sachs | $175 → $169 | Maintains | Buy | |||
03/24/2025 | 7.64% | UBS | $156 → $160 | Upgrade | Neutral → Buy | |||
03/11/2025 | 4.94% | JP Morgan | $150 → $156 | Maintains | Overweight | |||
03/07/2025 | 12.34% | Morgan Stanley | $154 → $167 | Maintains | Overweight | |||
02/03/2025 | 3.6% | Morgan Stanley | $166 → $154 | Maintains | Overweight | |||
01/29/2025 | 0.91% | JP Morgan | $152 → $150 | Maintains | Overweight | |||
01/29/2025 | -9.18% | Jefferies | $125 → $135 | Maintains | Hold | |||
01/17/2025 | 2.25% | JP Morgan | $168 → $152 | Maintains | Overweight | |||
01/06/2025 | -15.91% | Jefferies | $150 → $125 | Maintains | Hold | |||
12/19/2024 | 7.64% | Citigroup | $240 → $160 | Maintains | Buy | |||
12/17/2024 | -2.46% | BMO Capital | $145 → $145 | Maintains | Market Perform | |||
12/12/2024 | 4.94% | UBS | $171 → $156 | Downgrade | Buy → Neutral | |||
12/02/2024 | 27.82% | Goldman Sachs | → $190 | Initiates | → Buy | |||
10/23/2024 | 13.02% | JP Morgan | $170 → $168 | Maintains | Overweight | |||
10/23/2024 | 11.67% | Morgan Stanley | $170 → $166 | Maintains | Overweight | |||
10/09/2024 | 14.36% | JP Morgan | $174 → $170 | Maintains | Overweight | |||
09/18/2024 | 7.64% | BMO Capital | $175 → $160 | Maintains | Market Perform | |||
09/18/2024 | 14.36% | Morgan Stanley | $176 → $170 | Maintains | Overweight | |||
09/09/2024 | 17.05% | JP Morgan | $170 → $174 | Upgrade | Neutral → Overweight | |||
08/15/2024 | 18.4% | Morgan Stanley | $187 → $176 | Upgrade | Equal-Weight → Overweight | |||
07/16/2024 | 14.36% | JP Morgan | $180 → $170 | Maintains | Neutral | |||
06/26/2024 | 34.54% | B of A Securities | $210 → $200 | Maintains | Buy | |||
06/17/2024 | 17.73% | BMO Capital | $185 → $175 | Maintains | Market Perform | |||
06/11/2024 | 21.09% | JP Morgan | $190 → $180 | Maintains | Neutral | |||
05/20/2024 | 27.82% | Jefferies | → $190 | Initiates | → Hold | |||
04/24/2024 | 34.54% | BMO Capital | $210 → $200 | Maintains | Market Perform | |||
04/24/2024 | 27.82% | JP Morgan | $195 → $190 | Maintains | Neutral | |||
04/16/2024 | 31.18% | JP Morgan | $180 → $195 | Maintains | Neutral | |||
03/13/2024 | 61.45% | Citigroup | $180 → $240 | Upgrade | Neutral → Buy | |||
02/15/2024 | 25.8% | Morgan Stanley | $154 → $187 | Maintains | Equal-Weight | |||
01/16/2024 | 41.27% | UBS | → $210 | Initiates | → Buy | |||
12/12/2023 | 6.29% | JP Morgan | $151 → $158 | Maintains | Neutral | |||
10/31/2023 | 3.6% | Morgan Stanley | $162 → $154 | Maintains | Equal-Weight | |||
10/16/2023 | 1.58% | JP Morgan | → $151 | Upgrade | Underweight → Neutral | |||
09/08/2023 | 1.58% | JP Morgan | $150 → $151 | Maintains | Underweight | |||
07/27/2023 | 21.09% | Citigroup | $160 → $180 | Maintains | Neutral | |||
07/26/2023 | 8.98% | Morgan Stanley | $148 → $162 | Maintains | Equal-Weight | |||
07/11/2023 | 12.34% | Credit Suisse | $156 → $167 | Maintains | Outperform | |||
07/05/2023 | 28.49% | Exane BNP Paribas | → $191 | Upgrade | Neutral → Outperform | |||
06/21/2023 | -0.44% | Morgan Stanley | → $148 | Reiterates | → Equal-Weight | |||
06/01/2023 | — | Wolfe Research | — | Upgrade | Underperform → Peer Perform | |||
05/23/2023 | -12.55% | JP Morgan | → $130 | Initiates | → Underweight | |||
05/22/2023 | -0.44% | Morgan Stanley | $133 → $148 | Maintains | Equal-Weight | |||
04/24/2023 | -10.53% | Morgan Stanley | $131 → $133 | Maintains | Equal-Weight | |||
03/20/2023 | -11.87% | Morgan Stanley | $122 → $131 | Maintains | Equal-Weight | |||
03/17/2023 | 4.94% | Credit Suisse | $140 → $156 | Maintains | Outperform | |||
03/13/2023 | 8.31% | Goldman Sachs | $144 → $161 | Maintains | Neutral | |||
03/10/2023 | 8.31% | Goldman Sachs | $144 → $161 | Maintains | Neutral | |||
01/30/2023 | -17.93% | Morgan Stanley | $113 → $122 | Maintains | Equal-Weight | |||
01/27/2023 | 11% | BMO Capital | $155 → $165 | Maintains | Market Perform | |||
01/04/2023 | 15.71% | B of A Securities | → $172 | Reinstates | → Buy | |||
12/06/2022 | -2.46% | UBS | $120 → $145 | Maintains | Neutral | |||
11/09/2022 | -4.47% | BMO Capital | $113 → $142 | Maintains | Market Perform | |||
10/24/2022 | -23.98% | Morgan Stanley | $115 → $113 | Maintains | Equal-Weight | |||
10/06/2022 | -23.31% | Goldman Sachs | $127 → $114 | Maintains | Neutral | |||
09/16/2022 | -5.82% | Credit Suisse | $165 → $140 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Nucor (NUE)?
El último precio objetivo de Nucor (NYSE:NUE) fue comunicado por Wells Fargo el agosto 14, 2025. La firma de analistas fijó un precio objetivo para $145.00 que espera NUE a fall dentro de 12 meses (un posible -2.46% downside). 26 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Nucor (NUE)?
La última calificación de analistas para Nucor (NYSE:NUE) fue proporcionada por Wells Fargo, y Nucor iniciado su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Nucor (NUE)?
La última revisión al alza de Nucor Corp se produjo en julio 31, 2025, cuando Jefferies elevó su precio objetivo a $170. Jefferies anteriormente tenía a hold para Nucor Corp.
¿Cuándo fue la última revisión a la baja de Nucor (NUE)?
La última revisión a la baja de Nucor Corp se produjo en diciembre 12, 2024, cuando UBS cambió su precio objetivo de $171 a $156 para Nucor Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Nucor (NUE)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Nucor, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Nucor se registró el agosto 14, 2025, por lo que la próxima calificación estará disponible en torno al agosto 14, 2026.
¿Es correcta la calificación de los analistas sobre Nucor (NUE)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Nucor (NUE) fue un iniciado con un precio objetivo de $0.00 a $145.00. El precio actual al que cotiza Nucor (NUE) es de $148.65, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.